Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on September 25, 2026

Sep. 25, 2026

Golfing Queen Foundation Announces Prodigi as Title Sponsor for 2026 All Sports Reunion: Legends & Executives Golf Invitationall

Indeterminate GlobeNewswire

Sep. 25, 2026

BioAge Labs to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 25, 2026

NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments

Indeterminate GlobeNewswire

Sep. 25, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Sep. 25, 2026

Dr. Praisey Thomas, née Yesudas, Announces Plans for Regional Dental Outreach in Itarsi

Indeterminate EIN Presswire

Sep. 25, 2026

Vita Pop Officially Launches in the U.S. with Kansas City Celebration at Rock Island Bridge

Indeterminate GlobeNewswire

Sep. 25, 2026

Greystone Provides $35.4 Million in Freddie Mac Financing for Multifamily Property in Naperville, Illinois

Indeterminate GlobeNewswire

Sep. 25, 2026

Taiwan Excellence’s “Galaxy Amusement Park” Comes to Life at Taiwan Expo USA 2026

Indeterminate GlobeNewswire

Sep. 25, 2026

HIMS Stockholders Have Rights – If You Lost Money Investing in Hims & Hers Health, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Indeterminate GlobeNewswire

Sep. 25, 2026

Optimove Ranked 1st in the Real-Time Personalization and Decisioning Use Case in the Gartner® 2026 Critical Capabilities for Multichannel Marketing Hubs

Indeterminate GlobeNewswire

Sep. 25, 2026

EB5 Capital Announces I-956F Approval for JF47 - The Aletto at Boca Raton

Indeterminate GlobeNewswire

Sep. 25, 2026

Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

Indeterminate GlobeNewswire

Sep. 25, 2026

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 25, 2026

Beyond the Fairways: Golf Opens a New Window onto Sanya

Indeterminate EIN Presswire

Sep. 25, 2026

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

Indeterminate GlobeNewswire

Sep. 25, 2026

Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study

Indeterminate GlobeNewswire

Sep. 25, 2026

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Indeterminate GlobeNewswire

Sep. 25, 2026

Walmart and Sam's Club Partnership Helps Strengthen Food Access Across North Texas

Indeterminate GlobeNewswire

Sep. 25, 2026

Knight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada's Top Growing Companies

Indeterminate GlobeNewswire

Sep. 25, 2026

Thérapeutique Knight inc. se hisse au 345e rang du huitième classement annuel du Globe and Mail des entreprises canadiennes à forte croissance

Indeterminate GlobeNewswire